Assay | Inhibition (%) | Assay | Inhibition (%) |
---|---|---|---|
Adenosine A1 | 0% @ 4 μM | Muscarinic M1 | 22% @ 4 μM |
Adenosine A2A | 3% @ 4 μM | Muscarinic M2 | 52% @ 4 μM |
Adrenergic α1A | 11% @ 2 μM | Muscarinic M3 | 27% @ 4 μM |
Adrenergic α1B | 25% @ 2 μM | Muscarinic M4 | 30% @ 4 μM |
Adrenergic α2A | 45% @ 1 μM | Muscarinic M5 | 28% @ 4 μM |
Adrenergic α2B | -2% @ 2 μM | Neurokinin NK1 | 15% @ 2 μM |
Adrenergic α2C | 76% @ 1 μM | Neurokinin NK2 | 0% @ 2 μM |
CCR1 | 9% @ 10 μM | Neurokinin NK3 | 0% @ 2 μM |
CCR2 | 9% @ 10 μM | Neuropeptide Y (Y1) | 4% @ 4 μM |
CCR3 | 17% @ 10 μM | Neuropeptide Y (Y2) | -9% @ 4 μM |
CCR5 | 10% @ 10 μM | Neuropeptide Y (Y4) | -2% @ 4 μM |
CCR7 | 0% @ 10 μM | Neuropeptide Y (Y5) | 12% @ 4 μM |
CXCR1 | 13% @ 10 μM | Nociceptin NOP1 | -21% @ 4 μM |
CXCR2 | 20% @ 10 μM | Delta opiate | 12% @ 4 μM |
Dopamine D1 | 6% @ 4 μM | Kappa opiate | 7% @ 4 μM |
Dopamine D2 | 41% @ 4 μM | Mu opiate | 22% @ 4 μM |
Dopamine D3 | 18% @ 10 μM | Prokineticin PKR1 | -1% @ 4 μM |
Dopamine D4.2 | 18% @ 10 μM | Prokineticin PKR2 | -5% @ 4 μM |
Histamine H1 | 46% @ 2 μM | Purinergic P2Y1 | 16% @ 4 μM |
Histamine H3 | 29% @ 2 μM | Purinergic P2Y12 | 10% @ 4 μM |
MCHR1 | 0% @ 10 μM | Serotonergic 5HT1A | 20% @ 4 μM |
MRGX1 | 1% @ 4 μM | Vasopressin (V1a) | 7% @ 4 μM |
MRGX2 | 25% @ 4 μM | Vasopressin (V1b) | 15% @ 4 μM |
 |  | Vasopressin (V2) | 18% @ 4 μM |
 |  | Vasopressin (oxytocin) | 12% @ 4 μM |
 |  | VR1N | 0% @ 4 μM |